ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer

Excision repair cross-complementation group 1 (ERCC1) protein has been associated with cisplatin resistance. The objective of this study was to investigate the correlation between ERCC1 protein levels and the therapeutic effect of individualized therapy in advanced non-small cell lung cancer (NSCLC)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: GAO, ZHIQIANG, HAN, BAOHUI, SHEN, JIE, GU, AIQIN, QI, DAJIANG, HUANG, JINSU, SHI, CHUNLEI, XIONG, LIWEN, ZHAO, YIZHUO, JIANG, LIYAN, WANG, HUIMIN, CHEN, YURONG
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2011
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440707/
https://ncbi.nlm.nih.gov/pubmed/22977580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.276
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars